Trials / Completed
CompletedNCT03604263
ArcticLine Feasibility Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Medtronic Cardiac Ablation Solutions · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the ArcticLine Feasibility Study is to collect preliminary safety and effectiveness data on the ArcticLine Catheter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ArcticLine Cardiac Cryoablation Catheter | Cryoablation |
Timeline
- Start date
- 2018-10-18
- Primary completion
- 2019-11-18
- Completion
- 2019-11-18
- First posted
- 2018-07-27
- Last updated
- 2025-02-13
- Results posted
- 2020-05-20
Locations
4 sites across 2 countries: United States, Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03604263. Inclusion in this directory is not an endorsement.